Education
About Us
Working with TipRanks
Follow Us
Olympus (OLYMY)
OTHER OTC:OLYMY
OLYMY Stock Chart & Stats
$12.65
$0.44(3.00%)
At close: 4:00 PM EST
$12.65
$0.44(3.00%)
Day’s Range― - ―
52-Week Range$11.11 - $15.47
Previous CloseN/A
Volume14.55K
Average Volume (3M)3.80K
Market Cap
$13.90B
Enterprise Value$13.63B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.9
Beta0.49
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding1,114,485,700
10 Day Avg. Volume2,360
30 Day Avg. Volume3,798
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Olympus News
OLYMY FAQ
What was Olympus’s price range in the past 12 months?
Olympus lowest stock price was $11.11 and its highest was $15.47 in the past 12 months.
What is Olympus’s market cap?
Olympus’s market cap is $13.90B.
When is Olympus’s upcoming earnings report date?
Olympus’s upcoming earnings report date is Aug 12, 2026 which is in 235 days.
How were Olympus’s earnings last quarter?
Olympus released its earnings results on Nov 07, 2025. The company reported $0.117 earnings per share for the quarter, missing the consensus estimate of $0.135 by -$0.018.
Is Olympus overvalued?
According to Wall Street analysts Olympus’s price is currently Overvalued.
Does Olympus pay dividends?
Olympus does not currently pay dividends.
What is Olympus’s EPS estimate?
Olympus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Olympus have?
Olympus has 1,114,485,700 shares outstanding.
What happened to Olympus’s price movement after its last earnings report?
Olympus reported an EPS of $0.117 in its last earnings report, missing expectations of $0.135. Following the earnings report the stock price went up 1.664%.
Which hedge fund is a major shareholder of Olympus?
Currently, no hedge funds are holding shares in OLYMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Olympus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.59%
12-Months-Change
Fundamentals
Return on Equity
14.88%
Trailing 12-Months
Asset Growth
5.89%
Trailing 12-Months
Company Description
Olympus
Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
OLYMY Company Deck
OLYMY Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call highlighted upcoming product launches and strategic initiatives in robotics and cost management. However, significant revenue and profit declines, along with challenges in key markets and impacts from FDA alerts and tariffs, weigh heavily on performance.View all OLYMY earnings summariesTechnical Analysis
Baxter International
―
Encompass Health
―
Icon
―
United Therapeutics
―
Medpace Holdings
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---